EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI

Maria Concetta Pastore iD, Giulia Elena Mandoli, Alberto Giannoni, Francesca Rubina Ginetti, Michele Correale, Natale Daniele Brunetti, Andrea Igoren Guaricci, Laura Piscitelli, Anna Degiovanni, Giuseppe Patti, Alessandro Malagoli, Luca Moderato und 4 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15297 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Maria Concetta Pastore und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: Aminobutyrates, Heart Failure, Valsartan, Stroke Volume. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims Angiotensin receptor/neprilysin inhibitors (ARNI) have emerged as a pivotal medical treatment considerably improving the clinical outcome of patients with heart failure and reduced ejection fraction (HFrEF). Identifying individuals who stand to benefit the most from ARNI could markedly enhance patient management strategies. The aim of this sub-analysis of DISCOVER-ARNI register was to evaluate the prospective prognostic significance of speckle tracking echocardiography (STE) parameters in patients undergoing ARNI therapy. Methods and results DISCOVER-ARNI multicentre Italian register retrospectively enrolled 341 patients with HFrEF referred for treatment with ARNI. These patients underwent clinical, biohumuoral, and echocardiographic assessment at baseline. Subsequently, among those with available right ventricular STE data, a prospective long-term follow-up was conducted by telephone interview or on-site visits. The primary endpoint encompassed a composite of outcomes, including all-cause or cardiovascular mortality, heart failure hospitalization, heart transplantation, and left ventricular assist device (LVAD) implantation. Overall, 136 HFrEF patients were included in this sub-analysis (mean age 65 ± 10 years, 82% male). The mean follow-up was 40 ± 18 months, during which 32 patients reached the primary endpoint (14 deaths of which 10 due to cardiovascular reasons, 22 hospitalization, 3 heart transplantation, 1 LVAD implantation). Baseline assessment revealed that patients with events had higher LV volumes and EF (LV end-diastolic volume 212 ± 65 vs.174 ± 57 mL, P = 0.002; LV end-systolic volume 156 ± 52 vs. 122 ± 49 mL, P = 0.001; LV EF = 26 ± 5 vs. 29 ± 5 mL, P = 0.006, respectively), lower but preserved tricuspid annular plane systolic excursion (TAPSE, 17 ± 3 vs.19 ± 3, P = 0.008), and higher systolic pulmonary artery pressures (38 ± 11 vs. 31 ± 8 mmHg, P = 0.001) compared to those who did not experience events. LV, left atrial (LA), and free wall right ventricular longitudinal strain (fwRVLS) were reduced in patients with events (−7 ± 2 vs. −8 ± 2%, P = 0.002; 11 ± 3 vs. 15 ± 7%, P = 0.001 and −15 ± 5 vs. −22 ± 5%, P = 0.007, respectively). Employing Cox proportional hazard model including LVEF, TAPSE, RVFAC, LV strain, LA strain, and fwRVLS, the latest emerged as the sole independent predictor of the combined endpoint (hazard ratio = 1.15 [1.05;1.26], P = 0.002). Receiver operating characteristic (ROC) curves determined that fwRVLS = −20% was the optimal cut-off for predicting the combined endpoint (area under curve [AUC] = 0.70). This threshold was used for constructing Kaplan–Meier survival curves, demonstrating effective risk stratification of fwRVLS over long-term follow-up for the primary endpoint. Conclusions fwRVLS by STE holds promise as a valuable parameter to assess response to ARNI therapy in terms of overall survival, heart failure hospitalizations, heart transplantation, or LVAD implantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminobutyratesHeart FailureValsartanStroke VolumeVentricular Function, RightHeart VentriclesRegistriesHumansMaleFemaleDrug CombinationsAgedRetrospective StudiesBiphenyl CompoundsEchocardiographyAngiotensin Receptor AntagonistsFollow-Up StudiesPrognosisMiddle AgedProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Heart failurePrognosisRight ventricularSacubitril/valsartanSpeckle trackingStrain

Substanzen

AminobutyratesValsartansacubitril and valsartan sodium hydrate drug combinationDrug CombinationsBiphenyl CompoundsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
  • Cardiology and Cardiovascular Medicine Department, Fondazione Toscana G. Monasterio, Pisa, Italy.
  • Institute of Life Sciences, Scuola Superiore Sant'Anna Pisa, Pisa, Italy.
  • Cardiology Department, Policlinico Riuniti University Hospital, Foggia, Italy.
  • Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Interdisciplinary Department of Medicine, University Cardiology Unit, A.O.U.C. Polyclinic of Bari, Bari, Italy.

ORCID-Profile: Maria Concetta Pastore

Zitieren

APA

Pastore, M. C., Mandoli, G. E., Giannoni, A., Ginetti, F. R., Correale, M., Brunetti, N. D., Guaricci, A. I., Piscitelli, L., Degiovanni, A., Patti, G., Malagoli, A., Moderato, L., Carluccio, E., Marino, P. N., Emdin, M., & Cameli, M. (2025). Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI. ESC Heart Failure. https://doi.org/10.1002/ehf2.15297

Vancouver

Pastore MC, Mandoli GE, Giannoni A, Ginetti FR, Correale M, Brunetti ND, et al. Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI. ESC Heart Failure. 2025. doi:10.1002/ehf2.15297

BibTeX
@article{Pastore2025,
  author = {Pastore, Maria Concetta and Mandoli, Giulia Elena and Giannoni, Alberto and Ginetti, Francesca Rubina and Correale, Michele and Brunetti, Natale Daniele and Guaricci, Andrea Igoren and Piscitelli, Laura and Degiovanni, Anna and Patti, Giuseppe and Malagoli, Alessandro and Moderato, Luca and Carluccio, Erberto and Marino, Paolo N and Emdin, Michele and Cameli, Matteo},
  title = {Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15297}
}
Kostenlos starten →